Pathway Genomics has halted plans to commercialise a genetic testing kit in stores of US retail pharmacy Walgreens after the FDA raised fears about the product’s regulatory status. On 11 May, Pathway said that it was going to make its Genetic Health Report saliva test ...
Clinica
Pathway cancels plans for genetic test after FDA scrutiny
13 May 2010
Joseph Harvey
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
Other Informa News
Features & Analysis
Other Informa Analysis
EVENTS
19 March 2012
Montreux Convention and Music Centre, Switzerland
